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Purpose: Sonodynamic therapy is a developing noninvasive modality for cancer treatment, 
based on the selective activation of a sonosensitizer agent by acoustic cavitation. The activated 
sonosensitizer agent might generate reactive oxygen species leading to cancer cell death. We 
investigated the potential poly-methyl methacrylate core-shell nanoparticles (NPs) loaded 
with meso-tetrakis (4-sulfonatophenyl) porphyrin (TPPS) have to function as an innovative 
sonosensitizing system, ie, TPPS-NPs.
Methods: Shockwaves (SWs) generated by a piezoelectric device were used to induce acoustic 
cavitation. The cytotoxic effect of the sonodynamic treatment with TPPS-NPs and SWs was 
investigated on the human neuroblastoma cell line, SH-SY5Y. Cells were exposed for 12 hours 
to TPPS-NPs (100 µg/mL) and then to SWs (0.43 mJ/mm2 for 500 impulses, 4 impulses/second). 
Treatment with SWs, TPPS, and NPs alone or in combination was carried out as control.
Results: There was a statistically significant decrease in SH-SY5Y cell proliferation after 
the sonodynamic treatment with TPPS-NPs and SWs. Indeed, there was a significant increase 
in necrotic (16.91% ± 3.89%) and apoptotic (27.45% ± 3.03%) cells at 48 hours. Moreover, 
a 15-fold increase in reactive oxygen species production for cells exposed to TPPS-NPs and 
SWs was observed at 1 hour compared with untreated cells. A statistically significant enhanced 
mRNA (messenger ribonucleic acid) expression of NRF2 (P,0.001) and a significant down-
regulation of TIGAR (P,0.05) and MAP3K5 (P,0.05) genes was observed in cells exposed to 
TPPS-NPs and SWs at 24 hours, along with a statistically significant release of cytochrome c 
(P,0.01) at 48 hours. Lastly, the sonosensitizing system was also investigated in an in vitro 
three-dimensional model, and the sonodynamic treatment significantly decreased the neuro-
blastoma spheroid growth.
Conclusion: The sonosensitizing properties of TPPS were significantly enhanced once loaded 
onto NPs, thus enhancing the sonodynamic treatment’s efficacy in an in vitro neuroblastoma 
model.
Keywords: poly-methyl methacrylate nanoparticles, sonodynamic therapy, ultrasound, 
 shockwaves, cancer
Introduction
Although progress in basic research has led to the design of new generations of anti-
cancer targeted drugs with some notable achievements,1 further progress in cancer 
treatment may be also made by a more thorough investigation into other existing, but 
still poorly studied, therapeutic approaches. Amongst these, sonodynamic therapy 
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takes advantage of nonthermal ultrasound to activate chemi-
cal compounds known as sonosensitizer agents, such as 
the nontoxic hematoporphyrins, a group of chemicals that 
were originally used as light-activated agents. The activated 
sonosensitizer agent is then able to kill cancer cells through 
the generation of highly reactive products, such as reactive 
oxygen species (ROS).2–4 
This followed the assumption that inertial cavitation deter-
mined by acoustic waves at an appropriate energy fluency rate 
may cause an energy transfer which triggers electronic excita-
tion in the appropriate sonosensitizer agent.5 The attractive fea-
ture of this innovative modality for cancer treatment emerges 
from the fact that the ultrasound energy can be targeted directly 
onto deep-seated malignant cancer sites, overcoming one of 
the main drawbacks of the photodynamic therapy modality, ie, 
the shallow penetration of light through skin and tissues limit-
ing photodynamic therapy to the treatment of superficial and 
endoscopically reachable tumors.6 Sonodynamic therapy has 
two essential components: sonosensitizer agent and ultrasound. 
Although neither of these is individually cytotoxic, in combina-
tion they might be able to initiate a sonochemical reaction that 
culminates in cell death via apoptosis or necrosis.4
Nanoparticles (NPs) may enhance the sonodynamic 
therapy response by playing different roles: if properly 
engineered, when the sonosensitizer agent is loaded onto 
NPs, it passes more readily across the cell membrane, reach-
ing its critical intracellular target. It has been demonstrated 
that sonosensitizers loaded onto NPs are more readily taken 
up by cells than is the free drug.7 Indeed, the use of NPs 
as carriers makes for a high sonosensitizer payload, whilst 
preserving the sonochemical properties during the activa-
tion process. The surface charge on NPs plays an important 
role in the way NPs interact with cell surfaces, and it has 
been reported that cationic particles generally enhance cel-
lular uptake.8,9  Moreover, NPs are able not only to function 
as a sonosensitizer per se, but also as energy transducers.10 
Therefore, we engineered poly-methyl methacrylate core-
shell NPs so as to load the meso-tetrakis (4-sulfonatophe-
nyl) porphyrin (TPPS) onto their cationic surface to form 
an innovative sonosensitizing system, ie, TPPS-NPs. The 
synthetic water-soluble TPPS has been widely investigated 
as a photosensitizer because of its high tumor tissue affin-
ity and retention rate,11 as well as a remarkable quantum 
yield of singlet oxygen formation in solution.12 However, 
TPPS exploitation for photodynamic therapy applications 
has been hampered to date by its poor and unpredictable 
capability to readily pass the cell membrane and reach the 
critical intracellular target.13 Thus, the loading of TPPS onto 
NPs might well enhance the efficacy of the sonosensitizing 
system.
Our group introduced the use of shockwaves (SWs), 
characterized by microsecond pressure surges with a sudden 
peak positive pressure (up to values of about 100 MPa), fol-
lowed by a smaller peak negative pressure (about 10 MPa), 
to improve the energy transfer by acoustic cavitation. To date, 
SWs have been generally used for renal or hepatic concern-
ment disintegration and in orthopedics for the treatment of 
syndromes involving insertions. However, this treatment 
modality could be of greater interest if more attention were 
paid to its capability to transfer energy, rather than to its 
mechanical properties for damaged tissues.14 Indeed, it has 
already been reported that SWs generated by a piezoelectric 
device are able to elicit the electronic excitation of porphyrins 
by energy transfer, leading to cancer cell death in in vitro and 
in vivo models.15,16
Neuroblastoma, an embryonic tumor of the autonomic 
nervous system, is the most common cancer diagnosed dur-
ing the first year of life. It may follow various courses, from 
spontaneous regression to an aggressive treatment-resistant 
disease, which is often metastatic. The main obstacles to the 
treatment are acquired drug resistance and selection of rare 
resistant clones from a heterogeneous tumor  environment. 
This refractory form predominates over all others and has 
poor prognosis with only a 30% event-free survival at 
5 years.17 Therefore, we investigated whether TPPS-NPs 
were able to enhance the sonodynamic treatment with SWs 
in an in vitro two- and three-dimensional neuroblastoma 
model. Neuroblastoma tumors display various morpholo-
gies, and neuroblastoma-derived cell lines are classified on 
the basis of their appearance and expression profiles.18 The 
human cell line SH-SY5Y, representative of the aggressive 
neuronal “type I” histotype, was used, and the effects on cell 
proliferation were evaluated both in monolayer and spheroid 
culture. The sonodynamic activity of TPPS-NPs activated by 
SWs was also evaluated by analyzing the intracellular ROS 
generation, cell death, mRNA (messenger ribonucleic acid) 
gene expression and cytochrome c release.  Investigation was 
also carried out on the influence TPPS-loaded NPs have on 
SH-SY5Y proliferation in monolayer cell culture after pho-
todynamic treatment.
Materials and methods
NP synthesis and characterization
Poly-methyl methacrylate NPs were obtained using the 
following procedure. Briefly, an aqueous solution (50 mL) 
of methacryloyloxy-undecyl-dimethylethylammonium 
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bromide (see compound 2 in Figures S1, S2 and S3) (0.56 g, 
1.44 mmol) was introduced at room temperature into a 
250 mL three-neck reactor equipped with: a condenser, a 
mechanical stirrer, a thermometer, and inlets for nitrogen. 
The mixture was purged with nitrogen at a stirring rate of 
300 rpm and heated to +80°C. Methylmethacrylate (4.68 g, 
46.7 mmol) was then added to the aqueous solution. After 
10 minutes of equilibration time, 10 mg (0.037 mmol) 
of 2,2′-azobis(2-methylpropionamidine) dihydrochloride 
(AIBA) dissolved in 0.5 mL of MilliQ® (Merck Millipore, 
Billerica, MA, USA) water were added, and the mixture 
was allowed to react for 4 hours. The product was then 
purified by dialysis (against water) to remove any residual 
monomers and stabilizers.
The ultraviolet (UV) spectrum of the NPs and the amount 
of TPPS released were determined by spectrophotomet-
ric measurements with a Lambda 20 spectrophotometer 
 (PerkinElmer, Waltham, MA, USA). Supernatants were 
filtered with an  Amicon Ultra 0.5 mL 100 K Millipore 
 Filter (Merck Millipore) by an EBA 12 HETTIC centrifuge 
equipped with a F-205 FALC tube rotator. The hydrodynamic 
diameter of the nanospheres was determined by photon cor-
relation spectroscopy (PCS) at +25°C using a Zetasizer 3000 
HS system (Malvern Instruments, Malvern, UK) equipped 
with a 10 mV He-Ne laser. Data were analyzed on the basis 
of the viscosity and refractive index of pure water at +25°C. 
The instrument was calibrated with standard polystyrene 
latex particles, 200 nm in diameter. The sample was diluted 
in water to a concentration of 20 mg/mL. Electrophoretic 
mobility was evaluated by measuring the ζ-potential at +25°C 
using the same Zetasizer 3000 HS system. The instrument 
calibration was checked by standard polystyrene latexes, sup-
plied by Malvern Instruments with a known ζ-potential. The 
loading per gram of nanospheres of quaternary ammonium 
groups was determined by potentiometric titration of the 
chloride and bromide ions respectively obtained after com-
plete ion exchange. The ionic exchange was accomplished 
by dispersing 142.6 mg of the nanosphere sample in 25 mL 
of 1 M KNO
3
 at room temperature for 6 hours. The mixture 
was then adjusted to pH 2 with concentrated H
2
SO
4
, and 
bromide ions were titrated with a 0.012 M solution of AgNO
3
. 
Atomic force microscopy (AFM) samples were prepared by 
spin-coating deposition of NP solutions on atomic flat silicon 
substrate at 1,500 rpm. AFM images were performed in air 
and recorded using a Multimode IIIA (Bruker, Billerica, 
MA, USA) scanning probe. Imaging was done in tapping 
mode using a silicon RTESPA probe (Bruker;  frequency f0 
=270 KHz and nominal tip radius #15 nm).
TPPs loading and release experiments
Briefly, TPPS was combined with NPs by electrostatic 
interaction: a certain amount of porphyrin (typically from 
20 µg/mL to 150 µg/mL in MilliQ water) was added to an 
aqueous solution of positively charged NPs (0.5 mg/mL) 
and stirred at room temperature in a Vortex apparatus for 
20 seconds. Each sample was then centrifuged (4 minutes, 
4,722 relative centrifugal force) with a 100 kDa filter. The 
filtrate was analyzed by spectrophotometry at the appropri-
ate wavelength, generating a calibration curve for further 
determination of the loading values.
release procedure
The TPPS released from NPs was studied to ensure that 
it was the TPPS-NPs that generated the ROS during the 
experiments and not free TPPS that may have been released 
by NPs. To this aim, release experiments were performed 
as a function of saline concentration and time at +37°C 
and analyzed by spectrophotometric analysis (absorbance 
and fluorescence). A 100 kDa centrifugal filter tube, which 
is permeable by TPPS but not by TPPS-NPs and NPs, was 
used for the release experiments, which for more clarity has 
been depicted in Figure 1 and was performed as follows: 
1) 0.1 mL of TPPS-NPs in MilliQ water, corresponding to 
2.5 mg of NPs loaded with 250 µg of TPPS, were placed in a 
100 kDa centrifugal filter tube and suspended with 0.4 mL of 
releasing medium (phosphate-buffered saline [PBS], pH 7.4, 
150 mM, or cell culture medium) (Figure 1A); 2) the whole 
assembly was shaken at +37°C in a rotating stirring flat plate 
for predetermined time intervals (Figure 1B); 3) the solution 
was centrifuged-filtered for 4 minutes at 4,722 relative cen-
trifugal force, and the resulting bottom portion of the medium 
(0.4 mL), potentially containing TPPS, was analyzed by 
spectrophotometric analysis (Figure 1C); 4) 0.4 mL of fresh 
medium was added to the 100 kDa centrifugal filter tube to 
maintain a constant volume (Figure 1D).
100 kDa
filter
Shaking Centrifugalfiltration
Medium
addition
A B C D
Figure 1 TPPs release experiments.
Note: TPPs-NPs in MilliQ® water (Merck Millipore, Billerica, Ma, Usa) are placed 
in a 100 kDa centrifugal filter tube and suspended with releasing medium (A); 
the whole mixture was shaken at 37°c (B); the solution was centrifuged and the 
resulting bottom portion analyzed by spectrophoto metric analysis (C); an equal 
volume of fresh medium was added to the tube to maintain a constant volume (D).
Abbreviation: TPPs, meso-tetrakis (4-sulfonatophenyl) porphyrin.
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Considering that TPPS is completely water soluble 
(#6 mg/mL) and that the quantity present on our NPs was 
0.1 mg/mL, we can assume that the conditions used for the 
release experiments ensured sufficient dilution to allow for 
TPPS release.
TPPs-NP sample preparation  
for in vitro experiments
A total of 100 µL of TPPS (5 mg/mL in MilliQ water) was 
added to 70 µL of the NPs mother solution (71.3 mg/mL) so 
as to ensure a quantitative binding of porphyrin onto NPs (see 
calibration curve, Figure S4B). MilliQ water was then added to 
reach a total volume of 1 mL. Then, 200 µL of this TPPS-NP 
mother solution (5.0 mg
NPs
/mL; 500 µg
TPPS
/mg
NPs
) was then 
withdrawn and added to the plate, which contained 800 µL of 
culture medium. This meant that the NP concentration used for 
cell treatment was 1 mg
NPs
/mL, while all the experiments were 
carried out with a TPPS loading on the NPs of 100 µg
TPPS
/mg
NPs
, 
which is equivalent to 100 µg
TPPS
 of loaded TPPS per mL.
cell culture
The SH-SY5Y human neuroblastoma cell line (ICLC,  Interlab 
Cell Line Collection, Genova, Italy) was cultured in 50% Dul-
becco’s Modified Eagle’s Medium (DMEM) and 50% F-12 
(v/v) supplemented with 2 mM L-glutamine, 100 UI/mL 
penicillin, 100 µg/mL streptomycin and (Sigma, Milano, 
Italy) in a humidified atmosphere of 5% CO
2
 air at +37°C. 
The SH-SY5Y was detached using 0.05% trypsin-0.02% 
EDTA solution (Sigma), resuspended in culture medium and 
seeded at the appropriate cell concentration for cell culture 
experiments. The SH-SY5Y neuroblastoma spheroids were 
obtained through liquid overlay in agarose-coated 96-well 
plates, as reported by Friedrich et al,19 seeding 2.5 × 103 cells 
per well in 100 µL of culture medium.
In vitro sonodynamic treatment
The SH-SY5Y in the exponential growth phase was preincu-
bated in the dark for 12 hours with culture medium containing 
free or loaded TPPS (100 µg/mL) onto NPs. The cells were 
then removed from the flask with 0.05% trypsin-0.02% EDTA 
solution and normalized to 5 × 105 cells in 0.4 mL of PBS into 
96-well plates (TPP, Trasadingen, Switzerland). A piezoelec-
tric SW generator (Piezoson 100; Richard Wolf, Knittlingen, 
Germany) was used to generate focused SWs at an energy flux 
density (ie, the energy at the focal point) of 0.43 mJ/mm2 for 500 
impulses (4 impulses/second).  Common ultrasound gel was used 
as a contact medium between the device and the treated well. The 
in vitro SW treatment was delivered under a dim light.
In vitro photodynamic treatment
SH-SY5Y in the exponential growth phase was preincubated 
in the dark for 12 hours with culture medium containing 
free or loaded TPPS (100 µg/mL) onto NPs. The cells were 
then removed from the flask with 0.05% trypsin-0.02% 
EDTA solution and normalized to 1 × 105 cells in 1 mL of 
PBS into polystyrene tubes. A custom compact system for 
photodynamic treatment with fixed source-cuvette position-
ing and light diffuser all-around cell culture was used. The 
light-emitting source of the system is based on InGaN light-
emitting diodes (Cree Inc, Durham, NC, USA) with 20 mW 
max radiant power (emitted flux) and a central wavelength of 
405 nm. The system allows continuous radiant flux regulation 
from 0 to 20 mW with a programmable non-switching diode 
current source. The energy fluency rates of the UV radiation 
were adjusted to 15 mW/cm2 for 5 minutes, measured using 
Actinic UV-meter (Jelosil, Le Landeron, Switzerland).
cell proliferation assay
The WST-1 cell proliferation assay (Roche Applied Science, 
Penzberg, Germany) was used to evaluate any effects the 
treatment had on the SH-SY5Y cell growth. After the various 
treatments, 2.5 × 103 cells were seeded in 100 µL of culture 
medium in replicates (n=8) in 96-well culture plates. WST-1 
reagent (10 µL) was added at 24, 48, and 72 hours, and the 
plates were incubated at +37°C in 5% CO
2
 for 3.5 hours. The 
well absorbance was measured at 450 and 620 nm (reference 
wavelength) in a microplate reader (Asys UV340; Biochrom, 
Cambridge, UK). Cell proliferation data were expressed as 
a percentage of untreated cells.
Flow cytometric analyses
The TPPS cellular uptake, cell death, and ROS generation 
were assessed by a C6 flow cytometer (Accurri Cytom-
eters, Milano, Italy), and analyses were performed by FCS 
Express 4 (BD Bioscience, Milano, Italy). The intracellular 
fluorescence, determined by the photodynamic active sub-
stance (TPPS), was evaluated by flow cytometer at a 488 nm 
excitation (FL3), after cell exposure to TPPS or TPPS-NPs. 
It was expressed as the integrated median fluorescence 
intensity (iMFI), which was the product of the frequency of 
TPPS positive cells and the median fluorescence intensity of 
the cells. The most suitable TPPS or TPPS-NP concentration 
for the study, ie, the concentration able to reach more than 
50% of the cell population without significantly affecting 
cell viability, was chosen on the basis of the iMFI ratio. This 
ratio was the difference in the iMFI of treated and untreated 
cells over the iMFI of untreated cells.20
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Cell death was evaluated by the Dead Cell Apoptosis Kit 
with allophycocyanin (APC)-Annexin V and Sytox® Green 
(Life Technologies, Milano, Italy). Briefly, 5 × 105 SH-SY5Y 
cells were treated and washed twice at 24 and 48 hours with 
1× Annexin-binding buffer at 1,500 rpm for 5 minutes and 
then stained with APC-Annexin V and Sytox Green. The 
samples were run on the flow cytometer at 640 nm excita-
tion to measure APC-Annexin V (FL4) and at 488 nm to 
measure Sytox Green (FL1), respectively. Any cell debris 
with low FSC (forward light scatter) and SSC (side light 
scatter) were excluded from the analyses. A total of 10,000 
events were analyzed for APC-Annexin V (FL4) and Sytox 
Green (FL1) staining to discriminate apoptotic (Annexin V 
positive) and late apoptotic/necrotic cells (Annexin V and 
Sytox Green positive) from viable cells (Annexin V and 
Sytox Green negative).
The ROS generation was measured with the 
2,7- dichlorodihydrofluorescein (DCFH) diacetate (DA) 
(DCFH-DA; Molecular Probes, Carlsbad, CA, USA) as 
intracellular probe for oxidative stress. DCFH-DA is a 
stable, nonfluorescent molecule that readily crosses the cell 
membrane and is hydrolyzed by intracellular esterases to the 
nonfluorescent DCFH, which is rapidly oxidized in the pres-
ence of peroxides to highly fluorescent dichlorofluorescein 
(DCF) upon oxidation by ROS.21 Briefly, cells were incubated 
with 10 µM DCFH-DA for 30 minutes, washed with PBS, 
trypsinized, collected in 1 mL of PBS, and analyzed. The 
ROS production was expressed as the iMFI, which was the 
product of the frequency of ROS-producing cells and the 
median fluorescence intensity of the cells. The iMFI ratio was 
determined to yield the ratiometric increase in fluorescence 
per time point.20
Fluorescence microscopy observation  
of cytotoxicity
After the sonodynamic treatment with TPPS-NPs (100 µg/mL) 
and SWs (0.43 mJ/mm2 for 500 impulses, 4 impulses/second), 
25 × 103 SH-SY5Y cells were seeded in 1 mL of culture 
medium in 24-well plates and were allowed to attach for 
48 hours on glass coverslips in the wells. The Live/Dead 
Cell Double Staining Kit (Sigma) was then used for the 
simultaneous fluorescence staining of viable and nonviable 
cells. Briefly, this kit contains acetoxymethyl ester of cal-
cein (calcein-AM) and propidium iodide solutions, which 
stain viable and nonviable cells, respectively. Calcein-AM 
is highly lipophilic and cell-membrane permeable. Though 
calcein-AM itself is not a fluorescent molecule, the calcein 
generated from calcein-AM by esterase in a viable cell emits 
a strong green fluorescence. Alternatively, propidium iodide 
reaches the nucleus by passing through disordered areas 
of dead cell membrane and intercalates with the deoxy-
ribonucleic acid (DNA) double helix of the cell to emit 
a red  fluorescence. The coverslips were then mounted 
on glass slides, observed under fluorescence microscopy 
(DMI4000B Leica, Wetzlar, Germany) and photographed at 
63×  magnification. For the cell count, a total of 50 cells per 
slide were analyzed at a magnification of 40× in three separate 
areas, three times in three individual experiments.
real-time polymerase chain reaction 
(Pcr) analysis of oxidative stress-
associated gene expression
Total RNA was isolated from the SH-SY5Y cells at 24 hours 
after sonodynamic treatment. Briefly, cells were incubated for 
12 hours with TPPS, NPs, or TPPS-NPs at the same concen-
tration (100 µg/mL) and exposed to SWs at 0.43 mJ/mm2 for 
500 impulses (4/second). After 24 hours, the cells were then 
collected in an RNA cell protection reagent (Qiagen, Milano, 
Italy) and stored at −80°C. Total RNA was then obtained by 
the RNeasy® Plus Mini Kit (Qiagen). The total RNA con-
centration (µg/mL) was determined by the fluorometer Qubit 
(Invitrogen, Milano, Italy) and the Quant-iT™ RNA Assay 
Kit (Invitrogen); calibration was done applying a two-point 
standard curve, according to the manufacturer’s instructions. 
The integrity of the RNA samples was determined by the total 
RNA 6000 Nano Kit (Agilent  Technologies, Milano, Italy) by 
the Agilent 2100 Bioanalyzer (Agilent Technologies).
Real-time reverse transcriptase (RT)-PCR analysis 
was carried out using 500 ng of total RNA, which was 
reverse transcribed in a 20 µL cDNA (complementary 
DNA) reaction volume, using the QuantiTect® Reverse 
Transcription Kit (Qiagen), according to the  manufacturer’s 
instructions; 12.5 ng of cDNA was used for each 10 µL 
real-time RT-PCR reaction. Quantitative RT-PCR was 
performed using the SsoFast™ EvaGreen (Bio-Rad, 
Milan, Italy). QuantiTect Primer Assay (Qiagen) was 
used as the gene-specific primer pair for APAF1 (Cat No 
QT00092358), BAX (Cat No QT00031192), BCL2 (Cat No 
QT00025011), CDKN1A (Cat No QT00062090), GPX1 (Cat 
No QT00203392), HIF1A (Cat No QT00083664), MAP3K5 
(Cat No QT00041594), NRF2 (Cat No QT00027384), NQO1 
(Cat No QT00050281), RRN18S (Cat No QT00199367), 
SOD1 (Cat No QT01008651), TIGAR (Cat No QT00071225), 
and TP53 (Cat No QT00060235). The transcript of the 
reference gene ribosomal RNA 18S (RRN18S) was used to 
normalize mRNA data, and real-time PCR was performed 
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by a MiniOpticon™ Real Time PCR system (Bio-Rad). 
The PCR protocol conditions were as follows: HotStarTaq 
DNA polymerase activation step at +95°C for 30 seconds, 
followed by 40 cycles at +95°C for 5 seconds and +55°C 
for 10 seconds. All runs were performed with at least three 
independent cDNA preparations per sample, and all samples 
were run in duplicate. At least two non-template controls were 
included in all PCR runs. The quantification data analyses 
were performed using the Bio-Rad CFX Manager Software 
version 1.6 (Bio-Rad) according to the manufacturer’s 
instructions. These analyses were performed in compliance 
with the MIQE (Minimum Information for Publication of 
Quantitative Real-time PCR Experiments) guidelines.22
cytochrome c analysis
The cells were analyzed after 48 hours from the sonody-
namic treatment, ie, incubation in the dark with TPPS-NPs 
(100 µg/mL) for 12 hours followed by treatment with SWs 
at 0.43 mJ/mm2 for 500 impulses (4 impulses/second). 
 Cytosolic cytochrome c was then determined in supernatants 
from the selectively permeabilized cells using an enzyme-
linked immunosorbent assay (eBioscience, San Diego, CA, 
USA), following the manufacturer’s instructions. The con-
centration of cytochrome c was calibrated from a standard 
curve based on reference standards.
Neuroblastoma spheroid analysis
The SH-SY5Y cell suspensions (2.5 × 103 cells in 100 µL) 
were placed in a 96-well culture plate and treated for free 
association of cells to form multicellular tumor spheroids. 
The spheroid formation was analyzed after 3 days, and phase 
contrast photographs were taken in an inverted DMI4000B 
microscope (Leica, Wetzlar, Germany). The diameter of 
each neuroblastoma spheroid was measured by the Leica 
Application Suite Software (Leica) and the volume (V) was 
calculated by V =4/3πr3. According to the experimental set-
ting, spheroids were then treated with SWs at 0.43 mJ/mm2 
for 500 impulses (4 impulses/second) alone or in combination 
with TPPS or TPPS-NPs (100 µg/mL) preincubated in the 
dark for 12 hours. Both the integrity of the spheroid and the 
volume were then recorded at 24, 48, and 72 hours after 
the sonodynamic treatment. Data are presented as average ± 
standard deviation of three independent experiments with 
three replicates for each condition.
statistical analysis
Data are shown as the average values ± standard deviation 
of three independent experiments. Statistical analyses were 
performed with Graph-Pad Prism 5.0 software (La Jolla, CA, 
USA); two-way analysis of variance and Bonferroni’s test 
were used to calculate the threshold of significance. Statistical 
significance was set at P,0.05.
Results
TPPs-NP characterization
Core-shell NPs (Figure 2), obtained by emulsion polymeriza-
tion reaction, were characterized by an average hydrodynamic 
diameter of 93 ± 1.4 nm (five measurements; Table S1). The 
ammonium group loading, available for the interaction with 
TPPS, was determined by potentiometric titration of bromide 
ions obtained after complete ion exchange and was 265 µmol 
of quaternary ammonium bromides per gram of nanosphere 
(Figure S4A). Lastly, the ζ-potential of NPs (38.8 ± 2.4 mV), 
which was measured after dialysis purification, confirmed 
that the cationic co-monomer employed in the polymerization 
reaction is covalently bound to the NP surface (Table S2). 
AFM enabled the direct visualization of the NPs as well as 
the direct estimation of the radius distribution (Figure 2). 
The NPs were deposited on atomic flat silicon substrate 
spin-coating a solution of 0.14 mg/mL at 1,500 rpm. These 
experimental conditions prevented the aggregation of the 
NPs and realized a very uniform deposition over 1 cm2 of 
isolated NPs, which could be clearly distinguished from the 
substrate. The size distribution was calculated using a grain 
analysis algorithm (threshold chosen at 50% of the nano-
object height) and taking into account the overestimation of 
the measured size due to the finite size of the tip. The mean 
value of the radius was 72 ± 17 nm.
The difference in the NPs radii observed with PCS 
and AFM techniques could be ascribed to the different 
environments in which the measurements were performed, 
eg, water and air, respectively. The Stokes diameter mea-
sured with PCS corresponds to the size of the solvated NP, 
which was expanded due to the presence of the external 
ammonium groups; while AFM directly measured the dry 
radius.
NP stability evaluation
The stability of the TPPS-NP system was evaluated by 
mimicking physiological conditions using further PBS treat-
ment (150 mM) at +37°C and cell growth culture medium 
as the washing solution. The results of the spectrophoto-
metric analysis showed that there was no relevant release of 
TPPS from the nanospheres, under the reported conditions 
(Figure S5 and Figure S6A–D). As the amount of TPPS 
released was not detectable, absorbance measurements when 
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Figure 2 (A) representation of polymethyl methacrylate core-shell nanoparticles; (B) atomic force microscopy image of nanospheres deposited on atomic flat silicon 
Z-range =72 ± 17 nm; (C) distribution (%) of nanoparticle radius.
using PBS as washing solution were been reported, while 
TPPS release using culture medium is below 1% (Figure 
S6C and D to be compared with Figure S6A). Thus, we are 
confident that TPPS, even if electrostatically loaded onto 
the particles, is tightly bounded to the cationic shell, and no 
significant release from the spheres during in vitro experi-
ments is likely to occur.
effects of sonodynamic and photodynamic 
treatment with TPPs-NPs on sh-sY5Y 
cell proliferation
As shown in Table 1, exposing SH-SY5Y cells to TPPS or 
TPPS-NPs from 25 to 100 µg/mL for 12 hours did not affect 
cell viability. A dose-dependent increase of the iMFI ratio 
corresponding to the TPPS internalization was observed 
after TPPS or TPPS-NP incubation. Noteworthy is the fact 
that the iMFI was enhanced by TPPS loading onto NPs 
(Table 1). The sonodynamic effect on SH-SY5Y cell pro-
liferation was then evaluated after 48 hours of exposure to 
SWs of TPPS or TPPS-NP preincubated cells. Only when 
the cells were preincubated with TPPS-NPs were the sound 
waves able to significantly decrease SH-SY5Y cell prolif-
eration at an energy flux density of 0.43 mJ/mm2 for 500 
impulses (4/second) (Figure 3). Moreover, the decrease in 
cell proliferation was TPPS-NP dose-dependent (Figure 3). 
Therefore, we analyzed the effect sonodynamic therapy 
had on cell proliferation when cells were preincubated for 
12 hours with 100 µg/mL TPPS or TPPS-NPs as a function 
of time. Experiments were also carried out on the effects 
TPPS-NPs had on cell proliferation compared with TPPS 
alone when cells preincubated for 12 hours were exposed 
to an appropriate light beam (LB).
Interestingly control treatments, ie, cells exposed to 
unloaded NPs, SWs, or an LB alone or in combination, did 
not affect SH-SY5Y cell proliferation when compared with 
untreated cells (Figure 4A and B). Noteworthy was the fact 
that at the same concentration tested of 100 µg/mL, the 
TPPS-NPs enhanced the sonodynamic treatment efficacy 
compared with TPPS alone (Figure 4C). Whereas, both TPPS 
alone and TPPS loaded onto NPs exerted the same effect on 
SH-SY5Y cell proliferation in the photodynamic treatment 
(Figure 4D). The different activities observed of TPPS alone 
after SW or LB exposure might be ascribed to the inner lower 
energy locally generated by acoustic waves compared with 
light. For example, the strongest energy transfer produced 
by the photodynamic treatment might be less affected by cell 
internalization at the concentration tested (Table 1). On the 
other hand, the same activity observed with TPPS loaded 
Table 1 TPPs cellular uptake by sh-sY5Y after 12 hours of incubation
Concentration 
(μg/mL)
TPPS TPPS-NPs
Cell population (%) iMFI ratio Cell population (%) iMFI ratio
25 54.42 ± 6.94 39.61 ± 12.81 70.23 ± 5.62 86.47 ± 5.05a
50 73.19 ± 4.06 78.95 ± 3.33 97.42 ± 2.31b 190.23 ± 16.23b
100 85.01 ± 6.07 114.46 ± 8.31 97.98 ± 2.25 256.36 ± 15.35c
Notes: Statistically significant difference versus cells incubated with TPPS alone: aP,0.05; bP,0.01; cP,0.001.
Abbreviations: TPPS, meso-tetrakis (4-sulfonatophenyl) porphyrin; NPs, nanoparticles; iMFI, integrated median fluorescence intensity.
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Figure 4 effect of different treatment conditions on sh-sY5Y proliferation as a function of time. sonodynamic treatment was performed with sWs at 0.43 mJ/mm2 for 
500 impulses (4/second) and photodynamic therapy with an lB at 15 mW, for 5 minutes. The control conditions are reported on the upper panels (A and B), ie, treatments 
without the sensitizer, and the lower panels (C and D) report treatment on cells incubated for 12 hours with the sensitizer, ie, TPPs (100 µg/ml).
Notes: Cell proliferation was evaluated by WST-1 assay (Roche Applied Science, Penzberg, Germany). Statistically significant difference versus untreated cells: **P,0.01; 
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Figure 3 effect of sonodynamic treatment on sh-sY5Y proliferation as a function of sonosensitizer dose and formulations. cells were incubated for 12 hours with increasing 
concentration of TPPs or TPPs-NPs (25, 50, and 100 µg/ml) and then exposed to sWs at 0.43 mJ/mm2 for 500 impulses (4/second).
Notes: Cell proliferation was evaluated after 48 hours by WST-1 assay (Roche Applied Science, Penzberg, Germany). Statistically significant difference versus sonodynamic 
treatment with TPPs: **P,0.01; ***P,0.001.
Abbreviations: TPPs, meso-tetrakis (4-sulfonatophenyl) porphyrin; NPs, nanoparticles; sW, shockwave.
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onto NPs after SWs or an LB may be due to the presence of 
the NPs that lead to a decrease in the cavitation threshold, 
enhancing the sonodynamic treatment efficacy.
effects of sonodynamic treatment  
with TPPs-NPs on sh-sY5Y cell death
Depending on the cell proliferation data, SH-SY5Y cell death 
was evaluated after 48 hours from the sonodynamic treat-
ment with TPPS-NPs (100 µg/mL) and SWs by fluorescence 
microscopy and flow cytometry. As shown in Figure 5C, there 
were about 50% of nonviable cells in the whole cell popula-
tion stained with calcein-AM and propidium iodide. Fur-
thermore, flow cytometry was used to analyze the SH-SY5Y 
cells stained with APC-Annexin V and Sytox Green 48 hours 
after the sonodynamic treatment with TPPS (100 µg/mL), 
unloaded NPs (1 mg/mL), or TPPS-NPs (100 µg/mL) and 
SWs at 0.43 mJ/mm2 for 500 impulses (4/second), so as to 
determine whether the inhibition of cell growth was medi-
ated via apoptosis. Only the sonodynamic treatment with 
TPPS-NPs was able to induce a significant increase of the 
apoptotic (P,0.001) and necrotic (P,0.01) cell percent-
age when compared with the other treatment conditions 
(Table 2). Figure 5D shows representative flow cytometry 
density plots 48 hours after the sonodynamic treatment with 
TPPS or TPPS-NPs.
sh-sY5Y rOs generation after 
sonodynamic treatment with TPPs-NPs
DCFH-DA was used as a ROS probe to examine the ROS 
generation induced by the sonodynamic treatment. In fact, the 
highly fluorescent DCF can be determined by flow cytometry at 
an excitation of 488 nm (FL1) in the presence of peroxides.
The intracellular ROS levels were determined after 1, 5, 
30, and 60 minutes from the sonodynamic treatment with 
SWs alone or in combination with TPPS (100 µg/mL), 
unloaded NPs (1 mg/mL) or TPPS-NPs (100 µg/mL).
As shown in Figure 6, the sonodynamic treatment led 
to a slight increase in ROS generation 1 hour after the SW 
treatment of TPPS (P,0.05) or unloaded NP (P,0.05) 
exposed cells compared with cells treated only with SWs. 
Conversely, the sonodynamic treatment with TPPS-NPs led 
to a statistically significant increase in ROS generation as 
early as 1 minute (P,0.05) after the treatment, reaching a 
15-fold increase at 1 post-treatment hour (P,0.001).
effects of sonodynamic treatment  
with TPPs-NPs on oxidative stress-
associated gene expression  
and cytochrome c release
Real-time RT-PCR analysis was used to investigate the 
effect sonodynamic treatment has on the mRNA expression 
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Figure 5 effect of sonodynamic treatment on sh-sY5Y cell death. representative images of (A) viable cells stained with acetoxymethyl ester of calcein, (B) nonviable cells 
with propidium iodide, and (C) overlay image, after 48 hours from sonodynamic treatment with TPPs-NPs. cells were incubated for 12 hours with TPPs-NPs (100 µg/ml) 
and then exposed to sWs at 0.43 mJ/mm2 for 500 impulses (4/second). scale bars: 100 µm (63× magnification). (D) Representative flow cytometry density plots of SH-SY5Y 
at 48 hours from different treatment conditions: cells were exposed to sWs (0.43 mJ/mm2 for 500 impulses, 4/second) alone or after cell incubation for 12 hours with TPPs 
(100 µg/ml) or TPPs-NPs (100 µg/ml). The cells were stained with annexin V-aPc (Fl-4) and sytox® green (Fl-1). each density plot represents viable cells in the lower left 
quadrant (negative to aPc-annexin V and sytox green), apoptotic cells in the lower right quadrant (positive to aPc-annexin V and negative to sytox green), and necrotic 
cells in the upper right quadrant (positive to annexin V and sytox green).
Notes: sytox® green (life Technologies, Milano, Italy). annexin V-aPc (life Technologies).
Abbreviations: TPPs, meso-tetrakis (4-sulfonatophenyl) porphyrin; NPs, nanoparticles; sW, shockwave; aPc, allophycocyanin.
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Table 2 Flow cytometric evaluation of sh-sY5Y cell death after 
48 hours from different treatment conditions: cells were exposed 
to sWs (0.43 mJ/mm2 for 500 impulses, 4/second) alone or after 
cell incubation for 12 hours with TPPs (100 µg/ml), unloaded 
NPs (1 mg/ml), or TPPs-NPs (100 µg/ml)
Cell treatments Viable  
cells (%)
Apoptotic  
cells (%)
Necrotic  
cells (%)
Untreated cells 91.69 ± 1.56 4.80 ± 3.39 2.36 ± 3.10
sW 84.04 ± 2.44 13.22 ± 1.27 1.23 ± 1.61
TPPs + sW 85.48 ± 2.94 13.14 ± 4.81 2.03 ± 0.78
NPs + sW 83.63 ± 1.66 12.14 ± 2.45 2.56 ± 2.04
TPPs-NPs + sW 55.73 ± 4.99a 27.45 ± 3.03a 16.91 ± 3.89b
Note: Statistically significant difference versus untreated cells: aP,0.001; bP,0.01.
Abbreviations: sW, shockwave; TPPs, meso-tetrakis (4-sulfonatophenyl) 
porphyrin; NPs, nanoparticles.
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Figure 6 sh-sY5Y rOs production after different treatment conditions as a function of time. The cells were exposed to sWs at 0.43 mJ/mm2 for 500 impulses (4/second) 
alone or after cell incubation for 12 hours with TPPs (100 µg/ml), unloaded NPs (1 mg/ml), or TPPs-NPs (100 µg/ml).
Notes: ROS levels were determined according to the dichlorofluorescin-diacetate assay by flow cytometry and expressed as an iMFI ratio. Statistically significant difference 
versus untreated cells: *P,0.05; **P,0.01; ***P,0.001.
Abbreviations: ROS, reactive oxygen species; iMFI, integrated median fluorescence intensity; SW, shockwave; TPPS, meso-tetrakis (4-sulfonatophenyl) porphyrin; 
NPs, nanoparticles; min, minutes.
of genes involved in the apoptotic mechanism and in the 
oxidative stress after 24 post-treatment hours. As shown 
in Figure 7A, the mRNA expression of NRF2 coding for a 
transcription activator, which is essential for the coordinated 
upregulation of genes in response to oxidative stress, was 
significantly enhanced (P,0.001); whereas the mRNA 
expression of TIGAR coding for a protein that protects cells 
from DNA damage by ROS, and MAP3K5 coding for a pro-
tein with a crucial role in the apoptosis signal transduction 
pathway through mitochondria-dependent caspase activation 
were significantly downregulated (P,0.05) after the TPPS-
NPs and SW treatment compared with untreated cells.
Since cytochrome c release, which is peculiar to oxidative 
stress, may induce apoptosis, its release in cytosolic extracts 
of SH-SY5Y cells treated with TPPS-NPs for 12 hours and 
then exposed to SWs was assessed. As shown in Figure 7B, 
there was a statistically significant increase in the release 
of mitochondrial cytochrome c into cytosol after 48 hours 
from the sonodynamic treatment compared with untreated 
cells (P,0.01).
reduced spheroid size after  
sonodynamic treatment with TPPs-NPs
The growth rate of the neuroblastoma spheroids was moni-
tored by taking phase contrast images at different time points 
and calculating the spheroid volumes. It was evident as early 
on as 24 post-treatment hours that the SH-SY5Y spheroids 
treated with TPPS-NPs for 12 hours and then exposed to SWs 
were smaller in volume than the untreated spheroids, those 
treated with SWs alone, or those treated in combination with 
TPPS and SWs (Figure 8). Moreover, SW treated spheroids 
maintained their integrity.
Discussion
Although sonodynamic therapy is a promising new anticancer 
approach, its consistency as anticancer treatment modality 
has still to be established since its underlying mechanism has 
not yet been well defined. Some researchers have suggested 
that the activation of the sonosensitizer might be due to the 
acoustic cavitation induced by ultrasound propagation in a 
liquid milieu.4,23 The presence of particles in the liquid milieu 
might provide nucleation sites able to promote the cavitation 
activity. As these particles have a rough surface, this might 
lead to a decrease in the threshold intensity required for the 
acoustic cavitation occurrence, promoting a positive effect 
on the cavitation activity of ultrasound.24
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Figure 7 (A) mrNa expression analysis in sh-sY5Y cells at 24 hours from sonodynamic treatment. cells were incubated for 12 hours with TPPs, NPs, or TPPs-NPs at 
the same concentration (100 µg/ml) and then exposed to sWs at 0.43 mJ/mm2 for 500 impulses (4/second). RRN18S (ribosomal rNa 18s) was used as a reference gene to 
normalize the data. The sonodynamic therapy-induced alterations in mrNa levels were compared with those of the untreated cells stated as 1 and are shown by the dotted 
line. (B) cytochrome c release at 48 hours post sonodynamic treatment with TPPs-NPs. The cells were incubated for 12 hours with TPPs-NPs (100 µg/ml) and then exposed 
to sWs at 0.43 mJ/mm2 for 500 impulses (4/second).
Notes: Statistically significant difference versus untreated cells: *P,0.05; **P,0.01; ***P,0.001.
Abbreviations: TPPs, meso-tetrakis (4-sulfonatophenyl) porphyrin; sW, shockwave; NPs, nanoparticles; mrNa, messenger rNa; rNa, ribonucleic acid.
Therefore, it is more than reasonable to assume that 
properly designed NPs loaded with a sonosensitizer may 
not only act as an effective sonosensitizing vehicle capable 
of targeting tumor tissues and/or cells, but also as a tool 
to enhance the sonodynamic response. This led us to the 
investigation of whether a suitably tailored NP system might 
be able to enhance the sonodynamic activity in an in vitro 
neuroblastoma model.
Our data show that core-shell poly-methyl methacrylate 
NPs were able to significantly increase porphyrin incorpora-
tion into living cells (Table 1). Single cell treatments, such 
as exposure to SWs alone or TPPS alone, had no effect on 
SH-SY5Y cell proliferation. Indeed, the only sonodynamic 
treatment that showed a statistically significant decrease in 
SH-SY5Y cell proliferation was SWs in combination with 
TPPS-NPs (Figure 4), where this sonodynamic treatment 
significantly increased apoptotic cell death (Figure 5D and 
Table 2). As TPPS is commonly used in photodynamic 
therapy,25 we also investigated the influence of NPs on the 
photodynamic treatment of SH-SY5Y cells. Differently to 
the sonodynamic treatment, TPPS-NPs did not improve the 
photodynamic treatment efficacy compared with TPPS alone 
0
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Figure 8 The average volume of sh-sY5Y spheroids after different treatment conditions. The spheroids were exposed to sW alone or after incubation of spheroids for 12 
hours with TPPS or TPPS-NPs. Statistically significant difference versus untreated spheroids: **P<0.01, ***P<0.001.
Abbreviations: TPPs, meso-tetrakis (4-sulfonatophenyl) porphyrin; NPs, nanoparticles; sW, shockwave; h, hours.
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(Figure 4). This finding might be due to the different mecha-
nisms involved, as maybe the NPs act only as a sonosensitizing 
vehicle in photodynamic treatment, whilst in sonodynamic 
treatment they enhance the cavitation activity.
The sonodynamic mechanism of action was then 
investigated. The sonodynamic treatment with SWs of SH-
SY5Y cells exposed to TPPS-NPs increased the SH-SY5Y 
generation of ROS (Figure 6). The uncontrolled increase in 
the generation of free radicals may then exceed the capac-
ity of antioxidant mechanisms resulting in cell damage. 
A one-electron product of oxygen reduction, the  superoxide 
anion radical and its dismutation product, hydrogen  peroxide 
(H
2
O
2
), are among the mayor biologically relevant  free-radical 
species in cells. Although the DCF fluorescence is an assay 
of generalized oxidative stress rather than of any particular 
reactive species, the redox state of the sample monitored by 
detecting the increase in DCF fluorescence is assumed to 
be proportional to the concentration of hydrogen peroxide 
in the cells.21,26
Proapoptotic signals in the intrinsic apoptotic pathway, 
such as the proapoptotic protein Bax, translocate to mitochon-
dria, resulting in mitochondrial membrane permeabilization. 
This, in turn, provides a route for the release of intermem-
brane space proteins, such as cytochrome c, into the cytosol. 
The release of caspase activators, such as cytochrome c, is 
considered a point of no return for programmed cell death.27 
Sonodynamic treatment with TPPS-NPs and SWs was able 
to determine a statistically significant increase in cytoplas-
mic cytochrome c. This protein is highly redox-sensitive, 
since it acts as a reversible electron donor/acceptor, and 
the release of cytocrome c is considered to be a hallmark of 
mitochondrial-mediated apoptosis.28 Besides its function as 
an electron carrier, cytochrome c may act as a peroxidase.27 
Once in the cytosol, cytochrome c promotes the formation 
of the apoptosome, a molecular platform for the activation 
of caspase-9, leading to the expression of two key apoptotic 
phenotypes; namely, exposure of phosphatidylserine on the 
outer surface of plasma membrane and DNA degradation.29 
A statistically significant enhanced mRNA expression of 
NRF2 (P,0.001) and a statistically significant downregu-
lation of TIGAR (P,0.05) and MAP3K5 (P,0.05) genes 
were observed, 24 hours after the sonodynamic treatment 
with TPPS-NPs and SWs. Intracellular redox homeostasis 
regulates the expression of multiple gene-encoded proteins 
affecting cell death and survival. In response to alterations 
in the oxidative status, the transcription of those genes can, 
in part, be modulated through a redox control of transcrip-
tion factors.
As NRF2 (nuclear factor-erythroid 2-related factor 2) 
is a transcription factor, it acts as a sensor for oxidative/
electrophilic stress binding to the antioxidant response 
elements within promoters of antioxidant enzymes and 
detoxifying enzymes, such as NADPH (nicotinamide 
adenine dinucleotide phosphate) quinone oxidoreductase 
1 (NQO1).30 Reportedly, NRF2 is the main mediator of 
cellular adaptation to redox stress, since NRF2-dependent 
signal transduction can control cellular protection against 
oxidative stress-mediated cytotoxic effects. Other stress-
related transcription factors induced by oxidative stress 
include the hypoxia-inducible factor (HIF), and our data 
showed that the HIF expression was not affected 24 hours 
post sonodynamic treatment, as was true for the TP53 
expression. The p53 protein has both pro-oxidant and 
antioxidant functions and, albeit in different ways and with 
different outcomes, both can contribute to tumor suppres-
sion. Indeed, the p53 protein induces the transcription of 
the TIGAR gene (TP53-induced glycolysis and apoptosis 
regulator) gene, which lowers the intracellular concentra-
tions of fructose-2,6-bisphosphate, consequently decreasing 
glycolysis and overall levels of intracellular ROS. TIGAR 
uses this pathway to decrease ROS levels and lower sen-
sitivity to ROS-associated apoptosis. Therefore, TIGAR 
seems to function as a checkpoint for the negative regulation 
of glycolysis, and our data showed a statistically signifi-
cant decrease in the TIGAR mRNA expression 24 hours 
after sonodynamic treatment. It has been reported that the 
knockdown of the basal levels of TIGAR suffices to stimu-
late ROS-production and autophagy, in a p53-independent 
fashion, to levels mimicked by the exogenous addition of 
H
2
O
2
.31 Oxidative stress activates transcription of a variety 
of antioxidant genes governed by key signaling pathways 
involved in cellular oxidative responses.28,32 Hence, MAPK 
is a downstream effector in antioxidant responses and its 
activity plays a key role in transducing various extracellular 
signals to the nucleus.33
The effect of TPPS-NPs and SW sonodynamic treat-
ment on neuroblastoma multicellular tumor spheroids was 
evaluated as a supplement to monolayer-based assays before 
whole-animal studies. Noteworthy was the fact that this 
sonodynamic treatment was able to induce a statistically 
significant decrease in the growth of neuroblastoma spheroids 
without loss of their integrity.
Conclusion
TPPS loaded poly-methyl methacrylate NPs were able to 
improve the porphyrin sonodynamic activity in an in vitro 
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two- and three-dimensional model of human neuroblastoma. 
This new sonosensitizing system significantly decreased can-
cer cell growth after SW exposure, suggesting its potential 
application for further progress in sonodynamic anticancer 
therapy.
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Supplementary materials
Monomer synthesis
The cationic surfactant, methacryloyloxy-undecyl-dime-
thylethylammonium bromide (compound 2 in Figure S1) 
was obtained by following the previously reported pro-
cedure for the synthesis of its analog, MUTB (methacry-
loyloxy-undecyl-trimethylammonium bromide).1,2 Briefly, 
11-bromoundecanol (20 g, 0.08 mol, 1 eq) and 320 mL 
of anhydrous tetrahydrofuran were mixed in a flask at 0°C 
under N
2
, followed by the addition of 10.8 mL (0.11 mol, 
1.37 eq) of methacryloyl chloride. The reaction system was 
bubbled with N
2
 at room temperature for 2 hours and left 
under stirring overnight. The unreacted methacryloyl chlo-
ride and solvent were removed under reduced pressure. The 
yellowish residue was dissolved in ethyl ether and washed 
with saturated sodium hydrogen carbonate solution until the 
aqueous layer was basic. After evaporation of the ether, a 
viscous yellowish liquid of 11-bromoundecyl methacrylate 
(compound 1 in Figure S1) was obtained with a yield of 91%. 
O O
OO Br
Br
Monomer synthesis
N N
−
1 2
+
Figure S1 Monomer synthesis.
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Compound 2, with a yield of 58% was obtained by react-
ing compound 1 with N,N-dimethyl ethanamine (2.2 eq) 
in the presence of a small amount of hydroquinone to 
inhibit potential radical polymerization side reactions. 
After stirring the mixture under N
2
 at +40°C for 2 days, 
a solid was formed, which was washed with diethyl ether 
to remove excess amine, and crystallized with acetone. 
The final compound was than dried under vacuum at room 
temperature.
1HNMR (400 MHz, D
2
O) δ 5.94 (s, 1H), 5.51 (br s, 1H), 
4.55–4.73 (m, 2H), 3.99 (t, J =5.68 Hz, 2H), 3.28 (q, 
J =6.54 Hz, 2H), 3.09–3.22 (m, 2H), 2.83–3.03 (m, 6H), 
1.72–1.86 (m, 3H), 1.61 (br s, 2H), 1.44–1.58 (m, 2H), 1.22 
(br s, 9H), 1.16 (br s, 6H) ppm.
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Table S1 hydrodynamic diameter measurements by dynamic 
light scattering (MilliQ® water at +25°c)
Run Angle KCps ZAve PI Fit
1 90.0 165.4 95.7 0.201 0.000276
2 90.0 166.5 92.2 0.221 0.000190
3 90.0 168.5 92.4 0.248 0.000152
4 90.0 168.7 93.1 0.226 0.000195
5 90.0 170.3 93.1 0.258 0.000346
average 167.9 93.3 0.231
(±) 1.9 1.4 0.023
Note: MilliQ® (Merck Millipore, Billerica, Ma, Usa).
Abbreviations: PI, polydispersity index; Kcps, Kilocounts per second; Zave, 
average diameter.
Table S2 NP ζ-potential measurements (MilliQ® water)
Run Angle KCps Mobility ζ-potential Width
1 50.0 831.3 3.101 39.1 1.6
2 50.0 841.7 2.990 37.8 1.6
3 50.0 835.2 3.383 42.7 1.6
4 50.0 855.1 2.998 37.8 3.5
5 50.0 841.5 2.879 36.3 1.6
average 841.0 3.070 38.8 2.0
(±) 9.0 0.192 2.4 0.8
Note: MilliQ® (Merck Millipore, Billerica, Ma, Usa).
Abbreviations: NP, nanoparticle; Kcps, Kilocounts per second.
13CNMR (100 MHz, D
2
O) δ: 168.2, 136.4, 125.9, 65.3, 
63.5, 59.7, 50.3, 29.5, 29.4, 29.4, 29.2, 29.0, 28.5, 26.2, 25.9, 
22.3, 18.0, 7.9 ppm.
Nanosphere synthesis
Nu-C11-01 nanoparticles were obtained using the 
experimental procedure described as follows. An aque-
ous solution (50 mL) of compound 2 (0.56 g, 1.44 mmol) 
was introduced at room temperature into a 250 mL three-
neck reactor equipped with a condenser, a mechanical 
stirrer, a thermometer, and inlets for nitrogen. The mix-
ture was purged with nitrogen, at a stirring rate of 300 
rpm, and heated to +80°C. Methylmethacrylate (4.68 g, 
46.7 mmol) was then added to the water solution. After 
10 minutes equilibration time, 10 mg (0.037 mmol) 
of AIBA (2,2-azobis(2-methylpropionamidine) dihy-
drochloride) dissolved in 0.5 mL of MilliQ® (Merck 
Millipore, Billerica, MA, USA) water was added, and 
the mixture was allowed to react for 4 hours. At the 
end of the process, the product was purified by dialysis 
(against water) to remove residual monomer and 
stabilizer.
Nanoparticle characterization
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Figure S4 Nanoparticle titration curve (A) and loading calibration curve (B).
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Figure S5 TPPs (A) and TPPs-NPs (B) absorbance and photoluminescence spectra.
Abbreviations: TPPs, meso-tetrakis (4-sulfonatophenyl) porphyrin; NPs, nanoparticles.
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Figure S6 (A) Emission (fluorescence) spectra of TPPS-NPs (100 µg/mg) in different medium. (B–D) release experiments: (B) in PBs 150 mM at +37°c, emission 
(fluorescence) spectra of the filtrates at different times; (C) in culture medium at +37°C, emission (fluorescence) spectra of the filtrates at different times; (D) in culture 
medium at +37°C, absorbance spectra of the filtrates at different times.
Notes: In order for the curves to be at least partially in the scale range, we needed to reduce spectrofluorometer slit from 15 (completely opened) to 10. Absorbance 
spectra of the filtrates obtained from PBS release experiments have not been reported because they are below the detectable threshold.
Abbreviations: h, hours; TPPs, meso-tetrakis (4-sulfonatophenyl) porphyrin; NPs, nanoparticles; PBs, phosphate-buffered saline.
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